Urinary System Carcinoma — Trials

Urinary System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

2,394 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 670
Recruiting: 353
Ph III recruiting: 41
Growth YoY: +12.6%
Industry share: 31%
Top sponsor: National Cancer Institute (NCI)
Termination share: 41.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (391)

clinicaltrialsPublishedShowing 1–16 of 16 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02968732	Cystoscopic Evaluation Predicting pT0 Urothelial Carcinoma of the Bladder	active not recruiting	N/A	65	Fox Chase Cancer CenterOTHER	1	Sep 21, 2026	clinicaltrials
NCT04467021	Cancer and Blood Pressure Management, CARISMA Study	active not recruiting	N/A	61	ECOG-ACRIN Cancer Research GroupNETWORK	1	Sep 16, 2026	clinicaltrials